Our findings highlight the SIRT5-PPA2-NEDD4-mediated HIF-1α stability in promoting CRC metastasis and suggest a therapeutic approach that targets HIF-1α for the treatment of mCRC. This evidence concerns the gene SIRT5 and colorectal carcinoma.